The new position will advance a culture of innovation across the university.
The St. Louis-based company was founded on technology licensed through the Office of Technology Management at Washington University in St. Louis.
The device leverages brain-computer interface (BCI) technology developed at WashU.
Disarm Therapeutics was co-founded by Jeffrey Milbrandt, MD, PhD, and Aaron DiAntonio, MD, PhD, to speed the development of treatments for multiple neurodegenerative conditions.
The Office of Technology Management manages intellectual properties arising from research programs.
In the video, they demonstrate their breakthrough AR technology that visualizes a patient’s heart in 3D during surgery.
The event was designed to help close the funding gap for female startup founders.
The event took place June 25, 2020.
It’s that time of year! Fuse is excited to share the winners of the Fall 2019 Cycle LEAP Challenge.